Source - SMW
GlaxoSmithKline has confirmed that Luke Miels would start his appointment as president, global pharmaceuticals, on 4 September having reached an agreement with AstraZeneca.  


At 8:39am: (LON:GSK) GlaxoSmithKline PLC share price was +13.25p at 1708.75p